母婴同室与新生儿戒断综合征结局相关性的系统综述与荟萃分析
该系统综述与荟萃分析纳入6项研究共549名新生儿,比较母婴同室与标准NICU护理对新生儿戒断综合征(NAS)的结局。结果显示母婴同室显著降低药物治疗使用(RR 0.37,95%CI 0.19-0.71)和住院时长(WMD -10.41天,95%CI -16.84至-3.98天),且未增加再入院或院内不良事件。作者推荐母婴同室作为NAS首选住院护理模式。
要点
- 母婴同室与住院时长缩短约10.41天相关。
- 母婴同室未增加再入院率或院内不良事件。
核心结论
- 与NICU护理相比,母婴同室显著降低NAS新生儿药物治疗使用和住院时长,且不增加再入院或院内不良事件,应推荐为NAS首选住院护理模式。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、CINAHL、Cochrane Library和clinicaltrials.gov至2017年6月25日,纳入随机临床试验、队列研究、准实验研究和前后质量改进研究,共6项研究549名患者。
主要发现
- 荟萃分析6项研究显示母婴同室降低药物治疗使用(RR 0.37,95%CI 0.19-0.71;I²=85%)和住院时长(WMD -10.41天,95%CI -16.84至-3.98天;I²=91%)。
- 敏感性分析解决药物治疗使用的异质性,显著 favoring 母婴同室(RR 0.32,95%CI 0.18-0.57;I²=13%)。
- 3项研究报告母婴同室住院费用更低,但异质性显著未行定量分析。
- 定性分析支持母婴同室提高母乳喂养率和家庭监护出院率,但报告研究少。
- 母婴同室与再入院率或院内不良事件升高无关。
关键数值与推荐
- 药物治疗使用风险比RR 0.37(95%CI 0.19-0.71),敏感性分析RR 0.32(95%CI 0.18-0.57)。
- 住院时长加权均数差WMD -10.41天(95%CI -16.84至-3.98天)。
临床怎么用
- 对于阿片暴露新生儿,应优先考虑母婴同室护理模式,以降低药物治疗需求和缩短住院时间。
局限性
- 纳入研究数量较少(6项),药物治疗使用和住院时长分析存在显著异质性(I²分别为85%和91%)。
- 住院费用和母乳喂养等结局因异质性或研究太少未能定量分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Rising incidence of neonatal abstinence syndrome (NAS) is straining perinatal care systems. Newborns with NAS traditionally receive care in neonatal intensive care units (NICUs), but rooming-in with mother and family has been proposed to reduce the use of pharmacotherapy, length of stay (LOS), and cost. OBJECTIVE: To systematically review and meta-analyze if rooming-in is associated with improved outcomes for newborns with NAS. DATA SOURCES: MEDLINE, CINAHL, The Cochrane Library, and clinicaltrials.gov were searched from inception through June 25, 2017. STUDY SELECTION: This investigation included randomized clinical trials, cohort studies, quasi-experimental studies, and before-and-after quality improvement investigations comparing rooming-in vs standard NICU care for newborns with NAS. DATA EXTRACTION AND SYNTHESIS: Two independent investigators reviewed studies for inclusion. A random-effects model was used to pool dichotomous outcomes using risk ratio (RR) and 95% CI. The study evaluated continuous outcomes using weighted mean difference (WMD) and 95% CI. MAIN OUTCOMES AND MEASURES: The primary outcome was newborn treatment with pharmacotherapy. Secondary outcomes included LOS, inpatient cost, and harms from treatment, including in-hospital adverse events and readmission rates. RESULTS: Of 413 publications, 6 studies (n = 549 [number of patients]) met inclusion criteria. In meta-analysis of 6 studies, there was consistent evidence that rooming-in is preferable to NICU care for reducing both the use of pharmacotherapy (RR, 0.37; 95% CI, 0.19-0.71; I2 = 85%) and LOS (WMD, -10.41 days; 95% CI, -16.84 to -3.98 days; I2 = 91%). Sensitivity analysis resolved the heterogeneity for the use of pharmacotherapy, significantly favoring rooming-in (RR, 0.32; 95% CI, 0.18-0.57; I2 = 13%). Three studies reported that inpatient costs were lower with rooming-in; however, significant heterogeneity precluded quantitative analysis. Qualitative analysis favored rooming-in over NICU care for increasing breastfeeding rates and discharge home in familial custody, but few studies reported on these outcomes. Rooming-in was not associated with higher rates of readmission or in-hospital adverse events. CONCLUSIONS AND RELEVANCE: Opioid-exposed newborns rooming-in with mother or other family members appear to be significantly less likely to be treated with pharmacotherapy and have substantial reductions in LOS compared with those cared for in NICUs. Rooming-in should be recommended as a preferred inpatient care model for NAS.
引用
- MacMillan KDL, Rendon CP, Verma K, et al. Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis. JAMA Pediatr. 2018. PMID: 29404599. doi:10.1001/jamapediatrics.2017.5195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。